Study Management & Reporting

Understand more about how our solutions can help you gain a competitive advantage
Build effective trial strategies with disclosure in mind

Understanding global clinical trial disclosure requirements can help you refine site selection and change the protocol structure. Protocols written with disclosure in mind avoid unnecessary sharing of sensitive information, reduce redaction costs and incorporate plain language elements to meet regulatory requirements and support patient engagement initiatives.

Healthcare professionals collaborating around a tablet device.

Manage your study with disclosure in mind

When managing a clinical trial it is essential to understand the requirements of various international organizations and the changing regulatory requirements. Citeline provides global visibility into disclosure regulations through our world-class suite of TrialScope solutions and services, allowing sponsors to refine their regulatory strategy and transparency plans. Our specialized medical writers can write your study documents to manage the scope and efficiency of public disclosure, reduce the cost of redaction and anonymization, and support patient engagement initiatives.

Our insights publications can provide context and analysis behind the changing requirements and industry trends.

  • Monitor global disclosure regulations throughout the clinical life cycle
  • Plan site selection with transparency requirements in mind
  • Author your study documents to facilitate public disclosure, patient communication and redaction
  • Understand industry trends and stay abreast of changes in regulation
Speak to a Specialist
A specialist is ready to help find the solutions that are right for you.
Professionals submitting a form to find out more about Citeline.

Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.